Labshake search
Citations for R&D Systems :
401 - 450 of 4401 citations for Recombinant Human Aldehyde Dehydrogenase 1 Family Member A3 His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2020Quote: ... Recombinant human decorin protein (#143-DE-100) was purchased from R&D Systems (USA). Anti-decorin (#HPA064736) ...
-
bioRxiv - Immunology 2019Quote: ... overnight before addition of 500 IU/ml recombinant human IL-2 (R&D Systems).
-
bioRxiv - Immunology 2019Quote: ... media was supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems)(a survival factor) ...
-
bioRxiv - Biochemistry 2020Quote: ... Recombinant human MMP-2 (902-MP-010) was purchased from R&D systems (USA). Recombinant human MMP-3 (SRP7783 ...
-
bioRxiv - Biochemistry 2021Quote: ... Treatments with human recombinant 10 ng/ml TGF-β1 (R&D Systems, Minneapolis, MN) were performed after serum-free starvation for 12 hours (h).
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml transforming growth factor beta one (TGFβ1, recombinant human, R&D systems) 25 μg/mL l-ascorbic acid 2-phosphate (Sigma Aldrich) ...
-
bioRxiv - Developmental Biology 2021Quote: ... were embedded in a Bmp7 solution (R&D systems, Recombinant Human BMP7 #354-BP) in PBS ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant human TGFβ and Universal Type I IFN was obtained from R&D Systems.
-
Immunoresolvents Support Skeletal Myofiber Regeneration via Actions on Myeloid and Muscle Stem CellsbioRxiv - Immunology 2020Quote: ... and human recombinant GM-CSF (20 ng/mL) (R&D Systems, 215-GM-010). Cells then were washed with PBS to remove non-adherent cells and detached by incubation in TrypLE Select at 37°C followed by gentle cell scraping ...
-
bioRxiv - Cell Biology 2021Quote: ... Recombinant Human SHH Protein for SHH pathway activation was purchased from R&D systems.
-
bioRxiv - Immunology 2022Quote: ... in absence or presence of APRIL (Recombinant Human APRIL/TNFSF13 Protein, R&D systems) at 50 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... and 25 ng/mL human recombinant M-CSF (#216-MC, R&D Systems Inc). Cells were differentiated for 7-10 days prior to treatment as has previously been shown to yield mature macrophages (44) ...
-
bioRxiv - Cancer Biology 2022Quote: ... cells were stimulated with 50 ng/ml recombinant human BMP-9 (R&D Systems) and 150 ng/ml recombinant human VEGF (PeproTech ...
-
bioRxiv - Bioengineering 2022Quote: ... or 150 ng/ml recombinant human LOX homolog like 2 (LOXL2, R&D Systems), with media changed every 2-3 days ...
-
bioRxiv - Cell Biology 2022Quote: ... the samples were treated with human recombinant LOXL3 (RhLOXL3, R&D systems, 6069-AO) or LOXL2 (RhLOXL2 ...
-
bioRxiv - Immunology 2022Quote: ... 200 IU/ml of recombinant human IL-2 (R&D Systems, 202-IL-050) and expanded for 10 – 14 days ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems, Minneapolis, MN), recombinant human interleukin 4 (IL-4 ...
-
bioRxiv - Microbiology 2023Quote: ... Recombinant human Wnt-3a (rhWnt-3a) (#5036-WN, R&D Systems; Minneapolis, Minnesota, USA) was resuspended according to manufacturer’s instructions and stored at −80°C.
-
bioRxiv - Genetics 2023Quote: ... and recombinant human FGF2 at 20 ng/uL (R&D systems #233-FB-010).
-
bioRxiv - Cancer Biology 2023Quote: ... and 100 ng/mL of recombinant human IL-17B (R&D Systems, Minneapolis, MN) for 48 h and processed for downstream RNA expression analysis ...
-
ANGPTL8 R59W variant influences inflammation through modulating NF-κB pathway under TNFα stimulationbioRxiv - Biochemistry 2023Quote: ... the cells were treated with Recombinant Human TNFα Protein (R&D Systems, MN, USA) at 25ng/mL for 18 hours ...
-
bioRxiv - Biochemistry 2023Quote: ... we used commercial recombinant human OGT fragment (Cys323-Glu1041) (R&D systems, 8446-GT). Thereafter ...
-
bioRxiv - Cancer Biology 2023Quote: ... 200ng/mL recombinant Human Wnt3a (R&D System, Cat. No. 5036-WN-010/CF) or Wnt5a (R&D System ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 μM Y-27632 and 2 ng/mL human recombinant BMP4 (R&D Systems) and then cultured in ultra-low attachment 6 well plate (Corning ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/ml recombinant human M-CSF (R&D Systems 216-MC-100) at 37°C for seven days.
-
bioRxiv - Bioengineering 2023Quote: ... 1.5 mL CDM with 6 ng/mL human recombinant activin A (R&D Systems) and 5 ng/mL bFGF (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-4 (R&D systems, #204-IL/CF). Inhibitors used were the PI3Kdelta inhibitor Idelalisib ...
-
bioRxiv - Immunology 2024Quote: ... 2mM L-Glutamine and 20ng/mL of recombinant human IL-3 (R&D systems). Cas9 and gRNA components were assembled into RNP per the manufacturer’s instructions and transfected into pDC 16 hrs p.c ...
-
bioRxiv - Biochemistry 2023Quote: Recombinant human angiogenin (catalog number 265-AN/CF) was purchased from R&D Systems, a Bio-Techne Company (Minneapolis ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 20 ng/mL of recombinant human oncostatin M (OSM, R&D systems). For the co-culture experiment ...
-
bioRxiv - Biochemistry 2024Quote: Human recombinant CatA was first activated by following the manufacturer’s instructions (R&D Systems), incubating at 37°C 10 µg/mL CatA with 1 µg/mL CatL in an activation buffer (25 mM MES pH = 6.0 ...
-
bioRxiv - Bioengineering 2024Quote: ... along with 50 ng/ml recombinant human GDNF (R&D Systems, 212-GD-010) were administered for 12 hr ...
-
bioRxiv - Cell Biology 2020Quote: ... media was supplemented with 5 ng/mL recombinant human TGFβ-1 (R&D Systems; resuspended in 4 mM HCl, 0.1% BSA).
-
PVT1, a YAP1 dependent stress responsive lncRNA drives ovarian cancer metastasis and chemoresistancebioRxiv - Cancer Biology 2022Quote: ... epithelial to mesenchymal transition (EMT) was induced with 200 pM of Human recombinant TGF-beta 1 (R&D Systems, 240-B); verteporfin (Sigma Aldrich ...
-
bioRxiv - Cell Biology 2021Quote: ... media was supplemented with 5 ng/mL recombinant human TGFβ-1 (R&D Systems; resuspended in 4 mM HCl, 0.1% BSA). MCF7 ...
-
bioRxiv - Immunology 2020Quote: ... ELISA was performed in 96-well plates coated with 1 μg/mL of human recombinant IL13Rα2hFc (R&D Systems, Minneapolis, MN). Following blocking with PBS/2%FBS and washes with TBS-Tween 20 buffer (Boston Bioproducts ...
-
bioRxiv - Bioengineering 2023Quote: ... Fibroblasts were treated with or without recombinant human transforming growth factor beta 1 (TGF-β1) protein (240-B, R&D Systems) at 1.25 ng/mL ...
-
bioRxiv - Microbiology 2024Quote: ... Monocytes were differentiated into hMDMs for at least 7 days in complete medium containing 10 ng.mL-1 of recombinant human macrophage colony-stimulating factor (rhM-CSF; R&D systems).
-
bioRxiv - Cancer Biology 2021Quote: ... Recombinant SPARC (1 µM; R&D Systems) was incubated with self-activated pseudo-cath-D (5 nM ...
-
bioRxiv - Biochemistry 2020Quote: In vitro co-precipitation of TREM2 or TREM1 with Aβ oligomers was performed by mixing recombinant Fc-tagged TREM2 or TREM1 ectodomain (residues 19-171; 100 ng/ml, R&D systems), 100 nM HiLyte Fluor 647-labelled Aβ oligomers and Protein G Dynabeads in 0.5% fatty acid free BSA PBS-Tween buffer ...
-
bioRxiv - Immunology 2019Quote: ... Recombinant DLL4 (#1389-D4) and recombinant Jagged-1 (#Q63722) were purchased from R&D systems and coated on plates at the same time as anti-CD3/anti-CD28 ...
-
bioRxiv - Immunology 2019Quote: ... and resuspended for culture at 37°C + 5% CO2 for 1 h prior to stimulation with recombinant human TNFα (R&D Systems). Following stimulation ...
-
bioRxiv - Immunology 2020Quote: ... Cells were treated at 37 °C for 30 minutes with 15 μm Forskolin and 1:3 serial dilutions of potential ligands with the following starting concentrations: 10 μM recombinant human CXCL17 (R&D Systems), 10 μM lysophosphatidic acid (LPA ...
-
bioRxiv - Systems Biology 2019Quote: ... cells were washed with 1× Phosphate buffered saline (PBS) and stimulated with 1000 U/mL of human recombinant IFNβ (R&D Systems) in DMEM for the designated length of time ...
-
bioRxiv - Immunology 2023Quote: ... The culture was then diluted 1:50 in 1X PBS + 1% LB broth and incubated statically at 37°C with recombinant human SLPI protein (rSLPI) (CAS: 1274-PI-100, R&D Systems) at these final concentrations ...
-
bioRxiv - Cancer Biology 2024Quote: ... GPC2 CAR expression was determined using APC or PE-conjugated human recombinant GPC2 protein (R&D Systems; 2304-GP-050; 1:500) and CD19 CAR using PE-tagged protein L (58036S ...
-
bioRxiv - Developmental Biology 2019Quote: ... 0.01% of recombinant human FGF basic protein 10μg/ml (R&D Systems, #233-FB-025).
-
bioRxiv - Bioengineering 2021Quote: Recombinant human IDO expressed in Escherichia coli was purchased from R&D Systems (Minneapolis, MN) with a predicted molecular mass of 46 kDa a specific activity of >500pmoles/min/μg (or for equimolar calculations >29 pmol NFK/min/pmol IDO ...
-
bioRxiv - Cancer Biology 2020Quote: ... 10 ng/ml IL6 + 0.1 ng/ml recombinant human sgp130-Fc (R&D Systems, Germany) or 20 ng/ml Hyper-IL6 (kind gift of S ...
-
bioRxiv - Microbiology 2020Quote: ... infected HFF monolayers were stimulated with 100U/mL recombinant human IFN-γ (R&D Systems) 24 hours post-infection and fixed 6 hours post-stimulation ...